As the global COVID-19 pandemic spreads worldwide, new challenges arise in the clinical
landscape. The need for reliable diagnostic methods, treatments and vaccines for COVID-19 …

Background and Objectives: With an increasing number of severe COVID-19 cases
presenting with secondary fungal infections, this study aimed to determine the prevalence of …

Being considered minor vexations, fungal infections hinder the life of about 15% of the world
population superficially, with rare threats to life in case of invasive sepsis. A significant rise in …

A severe pandemic of Coronavirus Disease (COVID‐19) has been sweeping the globe
since 2019, and this time, it did not stop, with frequent mutations transforming into virulent …

Fungal co-infections are frequent in patients with coronavirus disease 2019 (COVID-19) and
can affect patient outcomes and hamper therapeutic efforts. Nonetheless, few studies have …

The epidemic of respiratory infection due to the new coronavirus SARS-CoV-2 that emerged
by the end of 2019 in China is now pandemic and associated with a huge number of deaths …

Severe cases of coronavirus disease 2019 (COVID-19) managed in the intensive care unit
are prone to complications, including secondary infections with opportunistic fungal …

Purpose The goal of our review was to gather information on the most important community-
acquired and hospital-acquired co-infections among coronavirus disease 2019 (COVID-19) …

Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …

Severe COVID-19 disease is associated with an increase in pro-inflammatory markers, such
as IL-1, IL-6, and tumor necrosis alpha, less CD4 interferon-gamma expression, and fewer …